Pages that link to "Q33903205"
Jump to navigation
Jump to search
The following pages link to Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial (Q33903205):
Displaying 50 items.
- Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure (Q21195009) (← links)
- Artificial and bioartificial support systems for liver failure (Q24247462) (← links)
- Clinical application of bioartificial liver support systems (Q24540124) (← links)
- Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure (Q24676081) (← links)
- Hepatorenal syndrome (Q24682192) (← links)
- The 21st International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 20-23 March 2001 (Q24796106) (← links)
- Equipment review: the molecular adsorbents recirculating system (MARS) (Q24801094) (← links)
- Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure (Q26771851) (← links)
- Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis (Q26773433) (← links)
- Hepatorenal syndrome: Update on diagnosis and treatment (Q26777608) (← links)
- Renal failure in cirrhosis: Emerging concepts (Q26785971) (← links)
- Clinical review: use of renal replacement therapies in special groups of ICU patients (Q26853350) (← links)
- Albumin for end-stage liver disease (Q26999804) (← links)
- Treatment and management of ascites and hepatorenal syndrome: an update (Q27000268) (← links)
- Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure (Q27499349) (← links)
- Outcomes of liver transplantation in patients with hepatorenal syndrome (Q28068506) (← links)
- Artificial and bioartificial liver support (Q28237883) (← links)
- Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice (Q30251763) (← links)
- Improvement in central nervous system functions during treatment of liver failure with albumin dialysis MARS--a review of clinical, biochemical, and electrophysiological data. (Q30771760) (← links)
- Life-threatening intoxication with methylene bis(thiocyanate): clinical picture and pitfalls. A case report (Q33239633) (← links)
- Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis (Q33345664) (← links)
- Postoperative complications of liver transplantation: relationship with mortality (Q33362801) (← links)
- Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating system (Q33395093) (← links)
- Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study (Q33558782) (← links)
- Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure (Q33844163) (← links)
- Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome (Q33979654) (← links)
- Personal view: current role of artificial liver support devices (Q33995791) (← links)
- Experiences with MARS liver support therapy in liver failure: analysis of 176 patients of the International MARS Registry (Q34148602) (← links)
- Albumin dialysis: single pass vs. recirculation (MARS). (Q34148606) (← links)
- Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child. (Q34149700) (← links)
- MARS treatment in posthepatectomy liver failure (Q34227085) (← links)
- Albumin dialysis in cirrhosis with superimposed acute liver injury: possible impact of albumin dialysis on hospitalization costs (Q34227092) (← links)
- Experience with albumin dialysis in five patients with severe overdoses of paracetamol (Q34229725) (← links)
- Prometheus--a new extracorporeal system for the treatment of liver failure (Q34279446) (← links)
- In vitro comparison of the molecular adsorbent recirculation system (MARS) and single-pass albumin dialysis (SPAD). (Q34318152) (← links)
- Catholic university experience with molecular adsorbent recycling system in patients with severe liver failure (Q34453646) (← links)
- Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices (Q34518397) (← links)
- Therapy insight: Management of hepatorenal syndrome. (Q34533221) (← links)
- Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I. (Q34542843) (← links)
- Molecular adsorbent recirculating system dialysis in patients with acute liver failure who are assessed for liver transplantation (Q34561715) (← links)
- Identification of patients best suited for combined liver-kidney transplantation: part II. (Q34575149) (← links)
- Drug insight: the role of albumin in the management of chronic liver disease (Q34597754) (← links)
- Dialysis modalities in the intensive care unit (Q34675365) (← links)
- Hepatorenal syndrome. Definition, pathophysiology, and intervention (Q34675396) (← links)
- Pharmaceutical strategies utilizing recombinant human serum albumin (Q34690229) (← links)
- Evaluation of the Hepa Wash® treatment in pigs with acute liver failure (Q34719069) (← links)
- Hepatorenal syndrome in patients with cirrhosis (Q34744285) (← links)
- What's new in the treatment of ascites and spontaneous bacterial peritonitis. (Q34770385) (← links)
- The pathophysiological basis of acute-on-chronic liver failure (Q34830328) (← links)
- Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol. (Q34975989) (← links)